Filament Health Corp. (OTC: FLHLF) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced that it has partnered with University College ...

Sanofi eyes filings for multiple sclerosis therapy tolebrutinib, although two of three phase 3 trials miss their primary endpoints.

Filament Health has collaborated with University College London (UCL) in the UK to provide its botanical psilocybin drug candidate, PEX010, for two Phase II research studies.

Kiro’s structured, agentic workflow challenges the Copilot model, offering a spec-first IDE with hooks, task orchestration, and enterprise-grade design generation.

Marvel's Phase 1, 2, 3, 4, 5 and 6 explained – what counts as which, and who is when? All you need to know about the MCU's Phases.

Dual three-phase interior permanent-magnet synchronous motor (IPMSM) drives have received more attention by the merits of better fault-tolerant capability and lower torque ripples. To improve the ...

This article proposes a systematic design methodology for a back-to-back (BtB) bridge structure to be used with three-phase bidirectional ac-ac converters (also called an active front end) feeding a ...

The dark skies during a new moon provide ideal conditions for spotting skywatching targets that would otherwise be outshined by moonlight.

VANCOUVER, BC, July 24, 2025 /CNW/ – Filament Health Corp. (OTC: FLHLF) (“ Filament ” or the “ Company “), a clinical‐stage natural psychedelic drug development company, today announced that it has ...

UCL will study PEX010, the company’s botanical psilocybin drug candidate, in trials investigating human perception, cognition, and therapeutic optimization “These studies represent two ...